236 related articles for article (PubMed ID: 21173143)
21. The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons.
Fiorentini C; Mattanza C; Collo G; Savoia P; Spano P; Missale C
J Neurochem; 2011 Apr; 117(2):253-63. PubMed ID: 21272002
[TBL] [Abstract][Full Text] [Related]
22. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease.
Sebastianutto I; Goyet E; Andreoli L; Font-Ingles J; Moreno-Delgado D; Bouquier N; Jahannault-Talignani C; Moutin E; Di Menna L; Maslava N; Pin JP; Fagni L; Nicoletti F; Ango F; Cenci MA; Perroy J
J Clin Invest; 2020 Mar; 130(3):1168-1184. PubMed ID: 32039920
[TBL] [Abstract][Full Text] [Related]
23. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade.
Chen J; Rusnak M; Luedtke RR; Sidhu A
J Biol Chem; 2004 Sep; 279(38):39317-30. PubMed ID: 15247297
[TBL] [Abstract][Full Text] [Related]
24. Agonist-induced activation of histamine H3 receptor signals to extracellular signal-regulated kinases 1 and 2 through PKC-, PLD-, and EGFR-dependent mechanisms.
Lai X; Ye L; Liao Y; Jin L; Ma Q; Lu B; Sun Y; Shi Y; Zhou N
J Neurochem; 2016 Apr; 137(2):200-15. PubMed ID: 26826667
[TBL] [Abstract][Full Text] [Related]
25. Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects.
Moreno E; Moreno-Delgado D; Navarro G; Hoffmann HM; Fuentes S; Rosell-Vilar S; Gasperini P; Rodríguez-Ruiz M; Medrano M; Mallol J; Cortés A; Casadó V; Lluís C; Ferré S; Ortiz J; Canela E; McCormick PJ
J Neurosci; 2014 Mar; 34(10):3545-58. PubMed ID: 24599455
[TBL] [Abstract][Full Text] [Related]
26. The magnificent two: histamine and the H3 receptor as key modulators of striatal circuitry.
Rapanelli M
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():36-40. PubMed ID: 27773554
[TBL] [Abstract][Full Text] [Related]
27. Histamine H
Varaschin RK; Osterstock G; Ducrot C; Leino S; Bourque MJ; Prado MAM; Prado VF; Salminen O; Rannanpää Née Nuutinen S; Trudeau LE
Neuroscience; 2018 Apr; 376():188-203. PubMed ID: 29374538
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.
Martínez-Pinilla E; Rodríguez-Pérez AI; Navarro G; Aguinaga D; Moreno E; Lanciego JL; Labandeira-García JL; Franco R
Biochem Pharmacol; 2015 Jul; 96(2):131-42. PubMed ID: 25986885
[TBL] [Abstract][Full Text] [Related]
29. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase.
Fuller G; Veitch K; Ho LK; Cruise L; Morris BJ
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):126-32. PubMed ID: 11311983
[TBL] [Abstract][Full Text] [Related]
30. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Papadeas ST; Blake BL; Knapp DJ; Breese GR
J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
[TBL] [Abstract][Full Text] [Related]
31. Histamine H
Aquino-Miranda G; Rivera-Ramírez N; Márquez-Gómez R; Escamilla-Sánchez J; González-Pantoja R; Ramos-Languren LE; Perez-Neri I; Bueno-Nava A; Ríos C; Arias-Montaño JA
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109653. PubMed ID: 31108178
[TBL] [Abstract][Full Text] [Related]
32. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
Bertran-Gonzalez J; Håkansson K; Borgkvist A; Irinopoulou T; Brami-Cherrier K; Usiello A; Greengard P; Hervé D; Girault JA; Valjent E; Fisone G
Neuropsychopharmacology; 2009 Jun; 34(7):1710-20. PubMed ID: 19158668
[TBL] [Abstract][Full Text] [Related]
33. Evidence against dopamine D1/D2 receptor heteromers.
Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
[TBL] [Abstract][Full Text] [Related]
34. Histamine H3 Receptor Regulates Sensorimotor Gating and Dopaminergic Signaling in the Striatum.
Kononoff Vanhanen J; Nuutinen S; Tuominen M; Panula P
J Pharmacol Exp Ther; 2016 May; 357(2):264-72. PubMed ID: 26945087
[TBL] [Abstract][Full Text] [Related]
35. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
Deng YP; Lei WL; Reiner A
J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
[TBL] [Abstract][Full Text] [Related]
36. Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.
Zhuang QX; Xu HT; Lu XJ; Li B; Yung WH; Wang JJ; Zhu JN
Mol Neurobiol; 2018 Oct; 55(10):8059-8070. PubMed ID: 29498008
[TBL] [Abstract][Full Text] [Related]
37. Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
Rico AJ; Dopeso-Reyes IG; Martínez-Pinilla E; Sucunza D; Pignataro D; Roda E; Marín-Ramos D; Labandeira-García JL; George SR; Franco R; Lanciego JL
Brain Struct Funct; 2017 May; 222(4):1767-1784. PubMed ID: 27612857
[TBL] [Abstract][Full Text] [Related]
38. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
39. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
West AR; Grace AA
J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
[TBL] [Abstract][Full Text] [Related]
40. Heteromers of μ opioid and dopamine D
Tao YM; Yu C; Wang WS; Hou YY; Xu XJ; Chi ZQ; Ding YQ; Wang YJ; Liu JG
Br J Pharmacol; 2017 Sep; 174(17):2842-2861. PubMed ID: 28608532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
